Dabigatran Impurity 22 | CAS 2733025-09-5 - Request Quote
Dabigatran Impurity 22
| SZ CAT No: | SZ-D012057 |
| CAS No | 2733025-09-5 |
| Mol.F. | C18H12N4O2 |
| Mol.Wt. | 316.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabigatran Impurity 22 is chemically 4,4'-(2,5-Dioxopiperazine-1,4-diyl)dibenzonitrile. Dabigatran Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2733025-09-5
Purchase 2733025-09-5
Order 2733025-09-5
Enquire 2733025-09-5
price of 2733025-09-5
2733025-09-5 Supplier
2733025-09-5 Manufacturer
2733025-09-5 Exporter
buy high quality Dabigatran Impurity 22
Purchase Dabigatran Impurity 22
Dabigatran Impurity 22 suppliers
Dabigatran Impurity 22 manufacturers
Dabigatran Impurity 22 price
Order Dabigatran Impurity 22
Enquire Dabigatran Impurity 22
Dabigatran Impurity 22 cost
Dabigatran Impurity 22 Supplier
Dabigatran Impurity 22 Distributor
Dabigatran Impurity 22 for Method Validation
Dabigatran Reference Standard
Dabigatran Impurity 22 for ANDA Filing
Dabigatran Impurity 22 for Forced Degradation Studies
Dabigatran Impurity 22 Identification Standards
Dabigatran Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.